Related Experiment Video
Updated: Apr 21, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
An update on travelers' diarrhea
1Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
Travelers' diarrhea remains a global health concern, with bacterial causes predominating and new pathogens emerging. Effective prevention and treatment strategies, especially for high-risk groups, are crucial for managing this common travel-related illness.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Public Health
Background:
- Travelers' diarrhea affects millions globally, posing a significant health challenge despite medical advancements.
- Gastroenterologists frequently manage complications, with certain patient groups exhibiting higher risk.
- Understanding recent progress in epidemiology, pathogenesis, diagnosis, prevention, and treatment is essential.
Purpose of the Study:
- To provide an updated review on travelers' diarrhea.
- To highlight recent advancements in understanding and managing this condition.
Main Methods:
- Literature review of recent progress in travelers' diarrhea.
Main Results:
- Bacterial pathogens are the primary cause, with emerging threats identified.
- Patient and travel factors influence risk and guide management strategies.
- Vaccines are under development but not yet widely impactful; prophylaxis and treatment for high-risk populations require tailored approaches.
Conclusions:
- Travelers' diarrhea poses ongoing challenges, with potential long-term complications.
- Future research should prioritize pathogen exposure reduction, vaccine development, early detection, and targeted therapies.
More Related Videos
06:55A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Bacterial Gastroenteritis
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Irritable Bowel Syndrome
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Cholera